title: Ticagrelor (Brilinta) for secondary prevention of thrombotic events following acute coronary syndrome.
authors.affiliation: The Chinese University of Hong Kong, Hong Kong, China.
authors.forename: Katrina
authors.initials: K
authors.lastname: Tsang
authors.affiliation: University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Hartmark-Hill
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications*; D000241:Adenosine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016527:Drug Costs; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control*; D058921:Purinergic P2Y Receptor Antagonists / Q000191:economics / Q000627:therapeutic use*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D000077486:Ticagrelor; D014481:United States
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine